Influencing Factors of Coronary Heart Disease in Young People

Sponsor
Hongzhuan Sheng (Other)
Overall Status
Recruiting
CT.gov ID
NCT05175495
Collaborator
Affiliated Hospital of Nantong University (Other)
1,000
1
36
27.8

Study Details

Study Description

Brief Summary

The incidence of coronary heart disease in young people is not uncommon and the investigators will explore the factors contributing to this outcome

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Through the multi-center clinical research conducted by several units in Nantong city, the risk factors and aggregation of the incidence of CHD among young people in nantong city were obtained, so as to fill in the blank of domestic multi-center research and reduce the incidence of CHD among young people.The investigators will conduct a long-term follow-up study on the young patients with CHD to screen the factors contributing to the poor prognosis of CHD in young patients.The investigators will fill this gap and intervene early to improve patients' quality of life and prolong their survival

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    To Study the Risk Factors of Youth Coronary Heart Disease From Inflammatory Cytokines,Lifestyle and Familial Inheritance
    Actual Study Start Date :
    Aug 1, 2021
    Anticipated Primary Completion Date :
    Aug 1, 2024
    Anticipated Study Completion Date :
    Aug 1, 2024

    Arms and Interventions

    Arm Intervention/Treatment
    Normal young

    Aged less than 45 years old,no underlying heart disease

    Young people diagnosed with coronary heart disease

    Aged less than 45 years old,Diagnosed coronary heart disease;Confirmed by coronary angiography;Diagnosed myocardial infarction;Typical symptom of ischemic chest pain with positive stress test;

    Coronary heart disease

    Older than 65 years, diagnosed with coronary heart disease

    Outcome Measures

    Primary Outcome Measures

    1. Whether inflammatory factors are differentially expressed in young patients with coronary heart disease [Until April 2024]

      The Investigators will analyze blood samples from the participants to see if there was a difference in the expression of inflammatory factors with high correlation compared with the control group by ELESA and High-throughput sequencing.

    2. The effect of gene activity on youth morbidity [Until April 2024]

      The investigators will use enrichment analysis to screen the target genes and sequence the participants.Whether the target gene was expressed at high levels in the participants.And the investigators will further analyze the target gene

    3. Sedentary, high-fat diet, lack of exercise and other unhealthy lifestyle effects on young people [Until April 2024]

      The researchers will retrospectively examine the participants' negative lifestyle habits, such as sedentary behavior, smoking, high-fat diet, and lack of exercise, in combination with their coronary angiography results

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Diagnosed coronary heart disease

    • Confirmed by coronary angiography

    • Diagnosed myocardial infarction

    • Willing to sign an inform consent

    Exclusion Criteria:
    • Patients won't sign an inform consent or will not comply with the follow up.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 shengHz Nantong Jiangsu China 226000

    Sponsors and Collaborators

    • Hongzhuan Sheng
    • Affiliated Hospital of Nantong University

    Investigators

    • Study Chair: hzh sheng, Dr., Affiliated Hospital of Nantong University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hongzhuan Sheng, Chief physician, Affiliated Hospital of Nantong University
    ClinicalTrials.gov Identifier:
    NCT05175495
    Other Study ID Numbers:
    • Observational
    First Posted:
    Jan 3, 2022
    Last Update Posted:
    Mar 2, 2022
    Last Verified:
    Mar 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hongzhuan Sheng, Chief physician, Affiliated Hospital of Nantong University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 2, 2022